Literature DB >> 2184115

Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis.

J Devière1, J Content, C Denys, P Vandenbussche, L Schandene, J Wybran, E Dupont.   

Abstract

The objective of this study was to analyze monokine production by peripheral blood mononuclear cells from patients with alcoholic cirrhosis. The capacity of peripheral blood mononuclear cells and purified monocytes from these patients to produce tumor necrosis factor alpha, interleukin 1 beta, and interleukin 6 was investigated. Spontaneous production of tumor necrosis factor alpha, interleukin 6 and interleukin 1 beta was similar in cirrhotic and healthy subjects, but serum levels of interleukin 6 (less than 2 U/ml vs. 9.5 +/- 3 U/ml) and tumor necrosis factor alpha (3.1 +/- 1.2 pg/ml vs. 12.0 +/- 1.2 pg/ml) were significantly higher in cirrhotic patients. However, peripheral blood mononuclear cells or purified monocytes from patients with alcoholic liver cirrhosis, stimulated in vitro with Escherichia coli lipopolysaccharide, displayed a marked increase of tumor necrosis factor alpha, interleukin 1 beta and interleukin 6 secretions compared with healthy controls. A striking feature of this overproduction was its reversibility as assessed by allowing cells to rest in vitro without lipopolysaccharide for 1 to 7 days before stimulation. In such conditions, tumor necrosis factor alpha and interleukin 6 secretions declined to levels present in healthy subjects in whom production remained stable, whereas interleukin 1 beta secretion markedly decreased in both groups to the point where no difference could be seen. This reversible oversecretion of cytokines after lipopolysaccharide stimulation, along with the lack of abnormality of spontaneous cytokine secretion, suggests that monocytes in these patients may have undergone an in vivo activation process analogous to a priming phenomenon. The in vitro activation with lipopolysaccharide may represent the correlate of in vivo endotoxemia observed during acute events such as sepsis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184115     DOI: 10.1002/hep.1840110416

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

1.  IL-6 and TNF alpha in ascitic fluid during spontaneous bacterial peritonitis.

Authors:  J Deviere; J Content; A Crusiaux; E Dupont
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

2.  Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection.

Authors:  J Such; D J Hillebrand; C Guarner; L Berk; P Zapater; J Westengard; C Peralta; G Soriano; J Pappas; B A Runyon
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

3.  Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection.

Authors:  C Meiler; M Muhlbauer; M Johann; A Hartmann; B Schnabl; N Wodarz; G Schmitz; J Scholmerich; C Hellerbrand
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

Review 4.  Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.

Authors:  F Wong; M Bernardi; R Balk; B Christman; R Moreau; G Garcia-Tsao; D Patch; G Soriano; J Hoefs; M Navasa
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

5.  Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.

Authors:  J C López-Talavera; A Levitzki; M Martínez; A Gazit; R Esteban; J Guardia
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

6.  Chronic biliary obstruction induces pulmonary intravascular phagocytosis and endotoxin sensitivity in rats.

Authors:  S W Chang; N Ohara
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Evaluation of sequential serum interleukin-6 levels in liver allograft recipients.

Authors:  Y Kita; Y Iwaki; A J Demetris; T E Starzl
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

Review 8.  Adrenal insufficiency in patients with decompensated cirrhosis.

Authors:  Apostolos Ka Karagiannis; Theodora Nakouti; Chrysoula Pipili; Evangelos Cholongitas
Journal:  World J Hepatol       Date:  2015-05-18

9.  Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis.

Authors:  M Márquez; C Fernández-Gutiérrez; M Montes-de-Oca; M J Blanco; F Brun; C Rodríguez-Ramos; J A Girón-González
Journal:  Clin Exp Immunol       Date:  2009-07-23       Impact factor: 4.330

10.  Down-regulation of tumor necrosis factor alpha activity by acute ethanol treatment in human peripheral blood monocytes.

Authors:  B K Verma; M Fogarasi; G Szabo
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.